Literature DB >> 18070124

A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-toxoplasma IgG avidity test.

P Flori1, B Bellete, C Crampe, A Maudry, H Patural, C Chauleur, J Hafid, H Raberin, R Tran Manh Sung.   

Abstract

A comparative evaluation of 384 selected sera was performed using the Beckman Coulter Access and Abbott Axsym Toxo-IgG assays. The Axsym assay yields positive early results following infection, while the Access assay gives higher titres during chronic infection. The ratio between the two complementary tests, Axsym Toxo-IgG/Access Toxo-IgG (Ax/Ac), was compared with the Vidas anti-Toxoplasma IgG avidity index (AI). The Ax/Ac ratio decreased progressively as the time between infection and sampling increased. The mean Ax/Ac values (+/-SE) were 2.50 (+/-0.26), 2.14 (+/-0.13), 2.33 (+/-0.22), 1.34 (+/-0.09), 1.32 (+/-0.10), 0.92 (+/-0.08) and 0.74 (+/-0.07) for groups of sera sampled at 1, 2, 3, 4-5, 6-8, 9-12 and 13-24 months, respectively, after infection in pregnant women. These values were much smaller for cases with chronic infection (>24 months), i.e., 0.56 (+/-0.03), 0.44 (+/-0.04) and 0.53 (+/-0.04), respectively, for pregnant women and immunodepressed patients with and without reactivation. Taking a ratio of 1 as a threshold for recent infection, the patients in the groups sampled at 1, 2 and 3 months had Ax/Ac ratios >1 in 49/50 (98%), 53/55 (96.4%) and 36/36 (100%) cases, respectively. Thus, an Ax/Ac ratio of <1 in serum from a pregnant woman allows a recent infection (<3 months) to be excluded. This technique has the advantage of yielding positive results that develop much more rapidly than the AI, thereby helping to reassure large numbers of pregnant women and avoiding costly and unnecessary prophylactic treatment and follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070124     DOI: 10.1111/j.1469-0691.2007.01905.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

1.  Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.

Authors:  Arnaud Maudry; Gautier Chene; Rémi Chatelain; Hugues Patural; Bahrie Bellete; Bernard Tisseur; Jamal Hafid; Hélène Raberin; Sophie Beretta; Roger Tran Manh Sung; Georges Belot; Pierre Flori
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

2.  Interpretation of the Elecsys Toxo IgG avidity results for very low and very high index: study on 741 sera with a determined date of toxoplasmosis.

Authors:  H Fricker-Hidalgo; C L'Ollivier; C Bosson; S Imbert; S Bailly; C Dard; R Piarroux; L Paris; H Pelloux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-19       Impact factor: 3.267

3.  Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.

Authors:  Jean-Benjamin Murat; Coralie L'Ollivier; Hélène Fricker Hidalgo; Jacqueline Franck; Hervé Pelloux; Renaud Piarroux
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

4.  Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies.

Authors:  O Villard; L Breit; B Cimon; J Franck; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

5.  Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Authors:  H Fricker-Hidalgo; B Cimon; C Chemla; M L Darde; L Delhaes; C L'ollivier; N Godineau; S Houze; L Paris; D Quinio; F Robert-Gangneux; O Villard; I Villena; E Candolfi; H Pelloux
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

6.  Seroprevalence of toxoplasmosis in voluntary blood donors of Puducherry and surrounding districts of Tamil Nadu.

Authors:  Selvaraj Stephen; Jothimani Pradeep; Velmurugan Anitharaj; Venkatraman Janarthanam
Journal:  J Parasit Dis       Date:  2017-07-25

Review 7.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

8.  IgG avidity ELISA test for diagnosis of acute toxoplasmosis in humans.

Authors:  Amir Hossien Rahbari; Hossien Keshavarz; Saeedeh Shojaee; Mehdi Mohebali; Mostafa Rezaeian
Journal:  Korean J Parasitol       Date:  2012-05-24       Impact factor: 1.341

9.  Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women.

Authors:  Aurélie Smets; Thomas Fauchier; Grégory Michel; Pierre Marty; Christelle Pomares
Journal:  Parasite       Date:  2016-10-20       Impact factor: 3.000

10.  Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria.

Authors:  Hajira Berredjem; Hayette Aouras; Meriem Benlaifa; Imène Becheker; Mohamed Reda Djebar
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.